Status:
COMPLETED
Omentopexy With Glubran®2 for Reducing Complications After Sleeve Gastrectomy
Lead Sponsor:
University of Salerno
Conditions:
Obesity With BMI >35
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
BACKGROUND. Gastric fistulas, bleeding, and strictures are commonly reported after laparoscopic sleeve gastrectomy (LSG), that increase morbidity and hospital stay and may put the patient's life at ri...
Detailed Description
The prospective randomized trial is designed with the aim to verify the effectiveness of the Glubran®2 used in its spray application, according to manufacturer's indications, to perform the omentopexy...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- body mass index (BMI) of greater than 40 kg/m2 or \> 35 with at least one co-morbidity, such as hypertension, dyslipidemia or diabetes,
- age ≥ 18 years old,
- medically unfit for surgical
- absence of active gastric disease, of uncontrolled medical or psychiatric conditions,
- signed informed consent.
- Exlusion criteria
- \- patient not suitable for bariatric surgery
Exclusion
Key Trial Info
Start Date :
January 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2017
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03833232
Start Date
January 1 2017
End Date
May 31 2017
Last Update
February 8 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.